Melanoma and Other Skin Cancers: Biology and Patient Management 2020

Saturday, November 7, 2020, 8:00 AM - 4:00 PM


In this interdisciplinary conference, an expert, international faculty will present clinical updates in melanoma biology, staging and early disease management. This includes novel approaches to melanoma detection and risk prediction. In addition, exciting advances in the treatment of patients with high-risk and metastatic disease will be discussed with a special emphasis on the multidisciplinary approach to the care of patients with melanoma. Other sessions will feature new data on the role of neoadjuvant and adjuvant therapy, the management of patients with brain metastases and leptomeningeal disease, duration of systemic therapy, changes in the role of surgery and the impact of various prognostic and predictive biomarkers on patient management. Concluding the day will be a session examining the latest approaches to the management of non-melanoma skin cancers. Case presentations and debates will address complex and controversial management issues in patients with high-risk and advanced melanoma and non-melanoma skin cancer.

1. Analyze and apply new insights in the diagnosis and treatment of advanced melanoma.
2. Use appropriate staging modalities to correctly gauge patient risk of recurrence and death and choose the most appropriate patient care strategy.
3. Discuss evolving research and treatment options for patients with disease resistant to IO +/- BRAF/MEK inhibitor therapy.
4. Recognize the value of multidisciplinary evaluation and assessment, in contributing to more effective and expedited patient treatment.
5. Assess new data on molecularly targeted therapies and novel immunotherapy in order to develop integrated treatment plans for patients with various molecular subtypes and stages of disease.
6. Incorporate salvage surgery and targeted radiation in selected patients to enhance long term outcomes.
7. Recognize the changing role in completion lymph node dissection.
8. Describe the new data on choice of combination vs. single agent immunotherapy.
9. Apply new data on adjuvant and neoadjuvant therapy.
10. Recognize new approaches to the management of patients with brain metastases and leptomeningeal disease.
11. Analyze and apply new insights in the treatment of non-melanoma skin cancers.

Registration is now complementary for healthcare providers!

• Physician $150 $0
• Resident and Fellow $50 $0
• Physician Assistant $75 $0
• Nurse Practitioner $75 $0
• Nurse $75 $0
• Allied Health Professional $75 $0
• Industry Professional $325
  
  
  

In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 6.25 Interprofessional Continuing Education (IPCE) credits for learning and change.

Physicians: MedStar Health designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nurses: This activity is approved for 6.25 ANCC contact hour(s). Nurses should claim only the credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credits™ Physician (6.75 hours), IPCE (6.75 hours), Non-Physician Member of the Healthcare Team (6.75 hours), Nurse - ANCC (6.75 hours)

Saturday, November 7, 2020

MedStar Health would like to acknowledge the generous educational grants from the following companies:

• Bristol-Myers Squibb
• Eisai Inc.
• Merck Sharp & Dohme Corp.
• Novartis Pharmaceuticals Corporation
• Pfizer Inc.

MedStar Health would like to acknowledge the  following exhibitors:

• Bristol-Myers Squibb
• Castle Biosciences
• Merck

Please contact Ada Guo at [email protected] for information on exhibiting at this conference.

Virtual Event FAQs:

WHEN AND HOW CAN I ACCESS THE VIRTUAL CONFERENCE?
Registered attendees will receive a link via email to the OnAir platform before the first live session begins on November 7. The link will be sent to the email address you used to register and is how you will access all of the conference content. You’ll use the same link to access the platform for the live conference and whenever you choose to view the on-demand content afterward.

WHAT IF I DON'T RECEIVE THE LINK?
Contact [email protected] and we will provide you with one.

CAN I SHARE THIS LINK WITH OTHERS?
Just like an in-person meeting, registrations cannot be shared. The registration provides a single sign-on secure experience for the user.

WILL SESSION MATERIALS BE MADE AVAILABLE IN ADVANCE OR AFTER SESSIONS HAVE BEEN COMPLETED?
Most session materials will be available as downloadable files (PDF) during the presentation on the session page. 

WILL LIVE CONTENT BE AVAILABLE AFTER THE EVENT?
Live content will be recorded, subject to speaker permission, and put on the platform for on-demand viewing. While the interactive chatrooms and other portions of the platform will close after the live event ends, you will still be available to view session content and click on exhibit booths to connect with exhibitors offline until July 2021.

AM I ABLE OR ALLOWED TO SHARE DOWNLOADABLE CONFERENCE CONTENT?
Please note that no recordings/sessions of any kind that are accessed on the platform can be downloaded (or shared) at any time. We ask that you follow the same rules for any presentation materials you download. This is a single sign-on/no group sharing of content, meaning your registration is just like a conference badge at an in-person event.